An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass pollen allergy

Clinical & Experimental Allergy, 05/10/2012

The optimisation of the formulation allows for administration of a lower dose of allergen while maintaining the immunogenicity of the product and at the same time reducing allergenicity.

Print Article Summary Cat 2 CME Report